Breast Cancer Organoids Derived from Patients: A Platform for Tailored Drug Screening.

[1]  J. van de Haar,et al.  Functional precision oncology using patient-derived assays: bridging genotype and phenotype , 2023, Nature Reviews Clinical Oncology.

[2]  Michael G. Lerner,et al.  Morphology-guided transcriptomic analysis of human pancreatic cancer organoids reveals microenvironmental signals that enhance invasion , 2023, The Journal of clinical investigation.

[3]  Yun-Shen Chan,et al.  A decade of liver organoids: Advances in disease modeling , 2023, Clinical and molecular hepatology.

[4]  O. Gluz,et al.  Molecular Profiling in Early ER + Breast Cancer to Aid Systemic Therapy Decisions , 2023, Current Oncology Reports.

[5]  B. Stockwell,et al.  Dietary restriction of cysteine and methionine sensitizes gliomas to ferroptosis and induces alterations in energetic metabolism , 2023, Nature Communications.

[6]  Ovijit Chaudhuri,et al.  Cell–extracellular matrix mechanotransduction in 3D , 2023, Nature Reviews Molecular Cell Biology.

[7]  C. Turato,et al.  Liver Organoids as an In Vitro Model to Study Primary Liver Cancer , 2023, International journal of molecular sciences.

[8]  G. Mælandsmo,et al.  Breast cancer patient-derived explant cultures recapitulate in vivo drug responses , 2023, Frontiers in Oncology.

[9]  T. Noda,et al.  Transcriptomic intratumor heterogeneity of breast cancer patient-derived organoids may reflect the unique biological features of the tumor of origin , 2023, Breast Cancer Research.

[10]  C. Retière,et al.  Donor selection for adoptive immunotherapy with NK cells in AML patients: Comparison between analysis of lytic NK cell clones and phenotypical identification of alloreactive NK cell repertoire , 2023, Frontiers in Immunology.

[11]  F. Spagnoli,et al.  3D multicellular systems in disease modelling: From organoids to organ-on-chip , 2023, Frontiers in Cell and Developmental Biology.

[12]  N. Lin,et al.  Epidemiology, clinical outcomes, and unmet needs of patients with human epidermal growth factor receptor 2-positive breast cancer and brain metastases: A systematic literature review. , 2023, Cancer treatment reviews.

[13]  L. Zhuang,et al.  Mimicking the Biological Sense of Taste In Vitro Using a Taste Organoids‐on‐a‐Chip System , 2023, Advanced science.

[14]  C. Suppan,et al.  Current Standards and Future Outlooks in Metastatic Her2-Positive Breast Cancer , 2022, Breast Care.

[15]  Huan-zhang Tang,et al.  Targeting cancer drug resistance utilizing organoid technology. , 2022, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[16]  K. Harada,et al.  Cancer organoid applications to investigate chemotherapy resistance , 2022, Frontiers in Molecular Biosciences.

[17]  Camila O. dos Santos,et al.  Clinical applications of 3D normal and breast cancer organoids: A review of concepts and methods , 2022, Experimental biology and medicine.

[18]  Shigao Huang,et al.  Advances in the application of 3D tumor models in precision oncology and drug screening , 2022, Frontiers in Bioengineering and Biotechnology.

[19]  C. Deng,et al.  Recent advances in organotypic tissue slice cultures for anticancer drug development , 2022, International journal of biological sciences.

[20]  S. Nik-Zainal,et al.  A living biobank of canine mammary tumor organoids as a comparative model for human breast cancer , 2022, bioRxiv.

[21]  H. Ulrich,et al.  Strategic use of organoids and organs-on-chip as biomimetic tools. , 2022, Seminars in cell & developmental biology.

[22]  Kexin Chen,et al.  Living biobank-based cancer organoids: prospects and challenges in cancer research , 2022, Cancer biology & medicine.

[23]  K. Tsui,et al.  Integrated analysis of pivotal biomarker of LSM1, immune cell infiltration and therapeutic drugs in breast cancer , 2022, Journal of cellular and molecular medicine.

[24]  Guangping Chen,et al.  Breast Cancer MCF-7 Cell Spheroid Culture for Drug Discovery and Development , 2022, Journal of cancer therapy.

[25]  G. Urban,et al.  Microfluidic organ-on-chip system for multi-analyte monitoring of metabolites in 3D cell cultures. , 2021, Lab on a chip.

[26]  A. Skardal,et al.  Strategies for Developing Complex Multi-Component In Vitro Tumor Models: Highlights in Glioblastoma. , 2021, Advanced drug delivery reviews.

[27]  Michael R Hamblin,et al.  The potential application of organoids in breast cancer research and treatment , 2021, Human Genetics.

[28]  Sourabh Ghosh,et al.  3D tumor angiogenesis models: recent advances and challenges , 2021, Journal of Cancer Research and Clinical Oncology.

[29]  H. Wathieu,et al.  In-depth characterization of a new patient-derived xenograft model for metaplastic breast carcinoma to identify viable biologic targets and patterns of matrix evolution within rare tumor types , 2021, Clinical and Translational Oncology.

[30]  W. Zimmermann.  Organs-on-chip models for cardiovascular drug development. , 2021, Cardiovascular research.

[31]  M. A. da Silva,et al.  Organ-on-Chip Approaches for Intestinal 3D In Vitro Modeling , 2021, Cellular and molecular gastroenterology and hepatology.

[32]  Xinyi Su,et al.  The Translational Application of Hydrogel for Organoid Technology: Challenges and Future Perspectives. , 2021, Macromolecular bioscience.

[33]  J. van den Eijnden-van Raaij,et al.  Organs-on-chip: The way forward , 2021, Stem cell reports.

[34]  M. Hou,et al.  Pathogenesis and Potential Therapeutic Targets for Triple-Negative Breast Cancer , 2021, Cancers.

[35]  L. Memeo,et al.  Microfluidic Organoids-on-a-Chip: Quantum Leap in Cancer Research , 2021, Cancers.

[36]  M. Nikkhah,et al.  Fabrication Method of a High-Density Co-Culture Tumor-Stroma Platform to Study Cancer Progression. , 2020, Methods in molecular biology.

[37]  S. Corso,et al.  Patient-Derived Cancer Models , 2020, Cancers.

[38]  E. Martin,et al.  Patient-Derived Xenografts as an Innovative Surrogate Tumor Model for the Investigation of Health Disparities in Triple Negative Breast Cancer , 2020, Women's health reports.

[39]  S. Bellis,et al.  Modulation of glycosyltransferase ST6Gal-I in gastric cancer-derived organoids disrupts homeostatic epithelial cell turnover , 2020, The Journal of Biological Chemistry.

[40]  L. del Peso,et al.  Comparative Study of Organoids from Patient-Derived Normal and Tumor Colon and Rectal Tissue , 2020, Cancers.

[41]  S. Zapperi,et al.  Cell–cell adhesion and 3D matrix confinement determine jamming transitions in breast cancer invasion , 2020, Nature Cell Biology.

[42]  C. Kuo,et al.  Organoid Models of Tumor Immunology , 2020, Trends in immunology.

[43]  J. Harrell,et al.  New generation breast cancer cell lines developed from patient-derived xenografts , 2020, Breast Cancer Research.

[44]  Katja G. Weinacht,et al.  Artificial thymic organoids represent a reliable tool to study T-cell differentiation in patients with severe T-cell lymphopenia. , 2020, Blood advances.

[45]  E. Cuppen,et al.  Challenges in Establishing Pure Lung Cancer Organoids Limit Their Utility for Personalized Medicine. , 2020, Cell reports.

[46]  H. Yamawaki,et al.  Development of Prostate Cancer Organoid Culture Models in Basic Medicine and Translational Research , 2020, Cancers.

[47]  Zhidong Wang,et al.  Adoptive Cell Therapy Targeting Neoantigens: A Frontier for Cancer Research , 2020, Frontiers in Immunology.

[48]  C. Isella,et al.  Patient-derived xenografts (PDXs) as model systems for human cancer. , 2020, Current opinion in biotechnology.

[49]  H. Clevers,et al.  Human Organoids: Tools for Understanding Biology and Treating Diseases. , 2020, Annual review of pathology.

[50]  G. J. Yoshida.  Applications of patient-derived tumor xenograft models and tumor organoids , 2020, Journal of Hematology & Oncology.

[51]  H. Wathieu,et al.  Evaluation of deacetylase inhibition in metaplastic breast carcinoma using multiple derivations of preclinical models of a new patient-derived tumor , 2019, bioRxiv.

[52]  Anil K. Kesarwani,et al.  Differential Functions of Splicing Factors in Mammary Transformation and Breast Cancer Metastasis. , 2019, Cell reports.

[53]  O. Elemento,et al.  Organotypic tumor slice cultures provide a versatile platform for immuno-oncology and drug discovery , 2019, Oncoimmunology.

[54]  J. Visvader,et al.  Modeling breast cancer using CRISPR/Cas9-mediated engineering of human breast organoids. , 2019, Journal of the National Cancer Institute.

[55]  C. Supuran,et al.  Personalized Treatment Response Assessment for Rare Childhood Tumors Using Microcalorimetry–Exemplified by Use of Carbonic Anhydrase IX and Aquaporin 1 Inhibitors , 2019, International journal of molecular sciences.

[56]  Li-Te Lin,et al.  Disruption of mitochondrial homeostasis with artemisinin unravels anti-angiogenesis effects via auto-paracrine mechanisms , 2019, Theranostics.

[57]  M. Meyerson,et al.  Patient-derived lung cancer organoids as in vitro cancer models for therapeutic screening , 2019, Nature Communications.

[58]  Giou-Teng Yiang,et al.  The Molecular Mechanism of Epithelial–Mesenchymal Transition for Breast Carcinogenesis , 2019, Biomolecules.

[59]  Kian Parsa,et al.  The promises and challenges of patient‐derived tumor organoids in drug development and precision oncology , 2019, Animal models and experimental medicine.

[60]  K. Chatterjee,et al.  Tissue mimetic 3D scaffold for breast tumor-derived organoid culture toward personalized chemotherapy. , 2019, Colloids and surfaces. B, Biointerfaces.

[61]  S. Mazzucchelli,et al.  Establishment and Morphological Characterization of Patient-Derived Organoids from Breast Cancer , 2019, Biological Procedures Online.

[62]  Sunghee E. Park,et al.  Organoids-on-a-chip , 2019, Science.

[63]  Hans Clevers,et al.  Cancer modeling meets human organoid technology , 2019, Science.

[64]  F. Hollande,et al.  Breast tumour organoids: promising models for the genomic and functional characterisation of breast cancer. , 2019, Biochemical Society transactions.

[65]  Donald E. Ingber,et al.  Modelling cancer in microfluidic human organs-on-chips , 2019, Nature Reviews Cancer.

[66]  P. van Luijk,et al.  Patient-derived tumor organoids for prediction of cancer treatment response. , 2018, Seminars in cancer biology.

[67]  R. Aft,et al.  Tumor-on-a-chip platform to investigate progression and drug sensitivity in cell lines and patient-derived organoids. , 2018, Lab on a chip.

[68]  Joshua M. Dempster,et al.  Genetic and transcriptional evolution alters cancer cell line drug response , 2018, Nature.

[69]  Hans Clevers,et al.  Organoids in cancer research , 2018, Nature Reviews Cancer.

[70]  N. Guzmán-Delgado,et al.  Breast Organotypic Cancer Models. , 2018, Current topics in microbiology and immunology.

[71]  J. Takagi,et al.  Human Pancreatic Tumor Organoids Reveal Loss of Stem Cell Niche Factor Dependence during Disease Progression. , 2018, Cell stem cell.

[72]  Andrea Sottoriva,et al.  Patient-derived organoids model treatment response of metastatic gastrointestinal cancers , 2018, Science.

[73]  E. Martin,et al.  A novel patient-derived xenograft model for claudin-low triple-negative breast cancer , 2018, Breast Cancer Research and Treatment.

[74]  D. McConkey,et al.  Three-dimensional organoid culture reveals involvement of Wnt/β-catenin pathway in proliferation of bladder cancer cells , 2018, Oncotarget.

[75]  Hans Clevers,et al.  A Living Biobank of Breast Cancer Organoids Captures Disease Heterogeneity , 2018, Cell.

[76]  A. Klein-Szanto,et al.  The Esophageal Organoid System Reveals Functional Interplay Between Notch and Cytokines in Reactive Epithelial Changes , 2018, Cellular and molecular gastroenterology and hepatology.

[77]  Bon-Kyoung Koo,et al.  Human Primary Liver Cancer -derived Organoid Cultures for disease modelling and drug screening , 2017, Nature Medicine.

[78]  E. Voest,et al.  Tumor Organoids as a Pre-clinical Cancer Model for Drug Discovery. , 2017, Cell chemical biology.

[79]  J. Bonventre,et al.  Kidney Organoids: A Translational Journey. , 2017, Trends in molecular medicine.

[80]  Roger D Kamm,et al.  On-chip human microvasculature assay for visualization and quantification of tumor cell extravasation dynamics , 2017, Nature Protocols.

[81]  Junfang Zhao,et al.  A novel biosensor based on intestinal 3D organoids for detecting the function of BCRP , 2017, Drug delivery.

[82]  Si Ming Man,et al.  NLRC3 is an inhibitory sensor of PI3K–mTOR pathways in cancer , 2016, Nature.

[83]  Zhonghu Bai,et al.  Cancer Hallmarks, Biomarkers and Breast Cancer Molecular Subtypes , 2016, Journal of Cancer.

[84]  J. Draper,et al.  Organoids as a model system for studying human lung development and disease. , 2016, Biochemical and biophysical research communications.

[85]  Jiaoti Huang,et al.  Prostate epithelial cell of origin determines cancer differentiation state in an organoid transformation assay , 2016, Proceedings of the National Academy of Sciences.

[86]  M. Untch,et al.  Intrinsic Subtypes of Primary Breast Cancer - Gene Expression Analysis , 2016, Oncology Research and Treatment.

[87]  L. Wilke,et al.  Analysis of Immune Cells from Human Mammary Ductal Epithelial Organoids Reveals Vδ2+ T Cells That Efficiently Target Breast Carcinoma Cells in the Presence of Bisphosphonate , 2016, Cancer Prevention Research.

[88]  Tetsuya Nakamura,et al.  Co-culture with intestinal epithelial organoids allows efficient expansion and motility analysis of intraepithelial lymphocytes , 2016, Journal of Gastroenterology.

[89]  Toshiro Sato,et al.  Mini-gut organoids: reconstitution of the stem cell niche. , 2015, Annual review of cell and developmental biology.

[90]  Hayley E. Francies,et al.  What role could organoids play in the personalization of cancer treatment? , 2015, Pharmacogenomics.

[91]  Hans Clevers,et al.  SnapShot: Growing Organoids from Stem Cells , 2015, Cell.

[92]  M. Spector,et al.  Organoid Models of Human and Mouse Ductal Pancreatic Cancer , 2015, Cell.

[93]  Hans Clevers,et al.  Long-Term Culture of Genome-Stable Bipotent Stem Cells from Adult Human Liver , 2015, Cell.

[94]  E. Maher,et al.  VHL, the story of a tumour suppressor gene , 2014, Nature Reviews Cancer.

[95]  Hans Clevers,et al.  Organoid Cultures Derived from Patients with Advanced Prostate Cancer , 2014, Cell.

[96]  Alex J Walsh,et al.  Quantitative optical imaging of primary tumor organoid metabolism predicts drug response in breast cancer. , 2014, Cancer research.

[97]  Kali T. Witherspoon,et al.  Refining analyses of copy number variation identifies specific genes associated with developmental delay , 2014, Nature Genetics.

[98]  M. Dunning,et al.  Genome-driven integrated classification of breast cancer validated in over 7,500 samples , 2014, Genome Biology.

[99]  Juergen A. Knoblich,et al.  Organogenesis in a dish: Modeling development and disease using organoid technologies , 2014, Science.

[100]  Sanjay Kumar,et al.  Microenvironmental Stiffness Enhances Glioma Cell Proliferation by Stimulating Epidermal Growth Factor Receptor Signaling , 2014, PloS one.

[101]  David W Grainger,et al.  Critical analysis of 3-D organoid in vitro cell culture models for high-throughput drug candidate toxicity assessments. , 2014, Advanced drug delivery reviews.

[102]  Andrew J. Ewald,et al.  Collective Invasion in Breast Cancer Requires a Conserved Basal Epithelial Program , 2013, Cell.

[103]  G. Hannon,et al.  Patient-derived tumor xenografts: transforming clinical samples into mouse models. , 2013, Cancer research.

[104]  Hans Clevers,et al.  Long-term expansion of epithelial organoids from human colon, adenoma, adenocarcinoma, and Barrett's epithelium. , 2011, Gastroenterology.

[105]  H. Clevers,et al.  Single Lgr5 stem cells build crypt–villus structures in vitro without a mesenchymal niche , 2009, Nature.

[106]  Trevor Hastie,et al.  Characterization of heterotypic interaction effects in vitro to deconvolute global gene expression profiles in cancer , 2007, Genome Biology.

[107]  A. Ewald,et al.  Organoid Co-culture Methods to Capture Cancer Cell-Natural Killer Cell Interactions. , 2022, Methods in molecular biology.

[108]  J. I. Izpisúa Belmonte,et al.  Organoids — Preclinical Models of Human Disease , 2019 .

[109]  Zuzana Koledova,et al.  3D Coculture of Mammary Organoids with Fibrospheres: A Model for Studying Epithelial-Stromal Interactions During Mammary Branching Morphogenesis. , 2017, Methods in molecular biology.

[110]  R. Roskoski.  The ErbB/HER family of protein-tyrosine kinases and cancer. , 2014, Pharmacological research.

[111]  R. West,et al.  Neuregulin autocrine signaling promotes self-renewal of breast tumor-initiating cells by triggering HER2/HER3 activation. , 2014, Cancer research.